We’re Here to Help

SNMMI's communications staff is available to handle your inquiries, arrange interviews with experts, provide copies of research articles and more.

For assistance, please contact Laurie Callahan, public relations, at lcallahan@snmmi.org or (703) 652-6773.


SNMMI is dedicated to being the premier source of information on nuclear medicine and molecular imaging. SNMMI's online newsroom provides reporters with the information needed to write articles and gain background information on the many topics related to molecular imaging and therapy and nuclear medicine.

SNMMI issues press releases on new research, society updates and industry news for members of the press. Check back frequently to see what's new with SNMMI.

View press releases on the latest research and news from SNMMI.

Nuclear and molecular imaging are vital elements of today's medical practice, adding an additional dimension to diagnosis that can change the way diseases are understood and treated. Nuclear medicine therapies treat specific diseases, such as lymphoma or thyroid cancer, by allowing a high dose of medicine to be delivered directly to a tumor or problem area. SNMMI's fact sheets explain how nuclear medicine and molecular imaging can help diagnose and/or treat a wide range of diseases.


SNMMI publishes two peer-reviewed medical journals—The Journal of Nuclear Medicine (JNM) and The Journal of Nuclear Medicine Technology (JNMT)which feature the latest in molecular imaging research. JNM and JNMT are the most widely read peer-reviewed publications in molecular imaging, nuclear medicine and allied disciplines.

Every month, JNM brings readers around the globe clinical investigations, basic science reports, continuing education articles, book reviews, employment opportunities, and updates on rapidly changing issues in practice and research. JNM's Newsline offers in-depth reporting on news affecting every facet of the field—the latest scientific events, government decisions, industry developments, socio-economic trends, and a broad selection of reviews from the literature.

Published quarterly, JNMT focuses on technology, quality assurance, radiation safety, and the clinical applications of nuclear medicine. Each issue features continuing education articles written by leading educators in nuclear medicine technology as well as news and updates on practice, licensure, and credentialing for nuclear medicine technologists. Practitioners from across the imaging sciences turn to JNMT for peer-reviewed information related to daily clinical practice.

SNMMI can connect you with subject-matter experts on a variety of topics who are ready to respond to tight deadlines. Contact Laurie Callahan, SNMMI's acting associate director of public relations, at lcallahan@snmmi.org or at (703) 652-6773, to set up an interview with SNMMI's leadership or with one of its many experts on oncology, brain disease, heart disease, radiopharmaceuticals, reimbursement and more.

SNMMI Leadership

  • Bennett S. Greenspan, MD, FACNM, FACR
    SNMMI President
  • Satoshi Minoshima, MD, PhD
    SNMMI President-Elect
  • Vasken Dilsizian, MD
    SNMMI Vice President-Elect
  • Sally W. Schwarz, MS, RPh, BCNP
    SNMMI Immediate Past President

SNMMI-TS Leadership

  • Kathleen M. Krisak, BS, CNMT, FSNMMI-TS
    SNMMI-TS President
  • Norman Bolus, MSPH, CNMT, FSNMMI-TS 
    SNMMI-TS President-Elect
  • Sara G. Johnson, MBA, CNMT, NCT, FSNMMI-TS
    SNMMI-TS Immediate Past President

Join SNMMI on our social media networks to stay updated on the latest from the society and the nuclear medicine and molecular imaging field.

Facebook Thumbnail Twitter LinkedIn YouTube Icon  

SNMMI 2018 Annual Meeting News, Announcements, Research
June 23-26, Philadelphia, Pennsylvania
Pennsylvania Convention Center

Scientific Research - (All releases embargoed. Please check embargo dates on releases when provided in advance; contact Laurie Callahan at lcallahan@snmmi.org, 703-652-6773-office, 571-294-1973-cell, if you need embargoed releases in advance)



General Clinical Specialties

Instrumentation and Data Analysis

Molecular Targeting Probes


Oncology - Basic

Oncology - Clinical

Also announced at the Annual Meeting: SNMMI Image of the Year, SNMMI/SNMMI-TS Officers, and Awards



  • March 23, 2018Partial Relief for High-Value Radiopharmaceuticals in Signed Budget Bill

    Buried in the Budget Bill that was just signed into law is a provision that provides some high-value radiopharmaceuticals partial and temporary relief. It also mandates that the Government Accountability Office study the problems with reimbursement for these drugs and report back to Congress.
    (Government Relations News)

  • March 22, 2018Societies Collaborate to Address Differentiated Thyroid Cancer

    Representatives of SNMMI, the European Association of Nuclear Medicine (EANM), the European Thyroid Association (ETA) and American Thyroid Association (ATA) met at the Multilateral Conference on Differentiated Thyroid Cancer and began working collaboratively on issues related to the care of patients with thyroid cancer, with particular focus on radioactive iodine (RAI) therapy.
    (SNMMI News)

  • March 21, 2018SNMMI Seeks Expanded Coverage for NaF PET

    SNMMI, the World Molecular Imaging Society (WMIS), and the American College of Radiology (ACR) are recommending that the Centers for Medicare and Medicaid Services (CMS) reconsider the current restrictive coverage policy for NaF PET imaging to identify bone metastases, which can inform treatment strategy.
    (Government Relations News)

  • March 15, 2018Patient Fly-In for Capitol Hill Advocacy: Bill to Reclassify Diagnostic Radiopharmaceuticals as Drugs

    Patients advocates with a wide range of health conditions—including neuroendocrine tumors, lymphoma and cancers of the lung, breast, and prostate—flew into Washington, DC, for March 14 meetings on Capitol Hill to urge support for a bill that would require the Centers for Medicare & Medicaid Services (CMS) to reclassify diagnostic radiopharmaceuticals as drugs. Patients rely on the radiopharmaceuticals for diagnosing and monitoring their conditions, as well as guiding therapy.
    (Government Relations News)

Featured Resources